BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 14609741)

  • 1. 2-Methoxy-3,8,9-trihydroxy coumestan: a new synthetic inhibitor of Na+,K+-ATPase with an original mechanism of action.
    Pôças ES; Costa PR; da Silva AJ; Noël F
    Biochem Pharmacol; 2003 Dec; 66(11):2169-76. PubMed ID: 14609741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic interaction between ouabain and 8-methoxy-3,9-dihydroxy coumestan, a non-steroidal synthetic inhibitor of Na+,K+-ATPase.
    Pôças ES; Touza NA; da Silva AJ; Costa PR; Noël F
    Life Sci; 2007 Sep; 81(15):1199-204. PubMed ID: 17884104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the mechanism of Na+,K+-ATPase inhibition by 2-methoxy-3,8,9-trihydroxy coumestan.
    Pôças ES; Touza NA; Pimenta PH; Leitão FB; Neto CD; da Silva AJ; Costa PR; Noël F
    Bioorg Med Chem; 2008 Oct; 16(19):8801-5. PubMed ID: 18805699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
    Fedorova OV; Bagrov AY
    Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that human endothelial cells express different isoforms of Na,K-ATPase.
    Mayol V; Dignat-George F; Gerbi A; Martin-Vasallo P; Lesaule G; Sampol J; Maixent JM
    J Hypertens; 1998 Feb; 16(2):145-50. PubMed ID: 9535140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
    Bagrov AY; Fedorova OV
    J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ouabain-sensitive Na+,K(+)-ATPase in the plasma membrane of Leishmania mexicana.
    Felibertt P; Bermúdez R; Cervino V; Dawidowicz K; Dagger F; Proverbio T; Marín R; Benaim G
    Mol Biochem Parasitol; 1995 Nov; 74(2):179-87. PubMed ID: 8719159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vanadate on ouabain binding and inhibition of (Na+ + K+)-ATPase.
    Myers TD; Boerth RC; Post RL
    Biochim Biophys Acta; 1979 Nov; 558(1):99-107. PubMed ID: 227460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase.
    Cherniavsky Lev M; Karlish SJ; Garty H
    Am J Physiol Cell Physiol; 2015 Jul; 309(2):C126-35. PubMed ID: 25994790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi epimastigotes express the ouabain- and vanadate-sensitive (Na(+)+K+)ATPase activity.
    Caruso-Neves C; Einicker-Lamas M; Chagas C; Oliveira MM; Vieyra A; Lopes AG
    Z Naturforsch C J Biosci; 1998; 53(11-12):1049-54. PubMed ID: 9933970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ouabain binds with high affinity to the Na,K-ATPase in human polycystic kidney cells and induces extracellular signal-regulated kinase activation and cell proliferation.
    Nguyen AN; Wallace DP; Blanco G
    J Am Soc Nephrol; 2007 Jan; 18(1):46-57. PubMed ID: 17151336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanadate-induced inhibition of renin secretion is unrelated to inhibition Na,K-ATPase activity.
    Churchill PC; Rossi NF; Churchill MC; Ellis VR
    Life Sci; 1990; 46(26):1953-9. PubMed ID: 2163483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of development on Na(+)/K(+)-ATPase expression: isoform- and tissue-dependency.
    Lopez LB; Quintas LE; Noël F
    Comp Biochem Physiol A Mol Integr Physiol; 2002 Feb; 131(2):323-33. PubMed ID: 11818222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic exposure to aluminium on isoform expression and activity of rat (Na+/K+)ATPase.
    Silva VS; Duarte AI; Rego AC; Oliveira CR; Gonçalves PP
    Toxicol Sci; 2005 Dec; 88(2):485-94. PubMed ID: 16162844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive [Na,K]ATPase assay specific for inhibitors acting through the digitalis-binding site.
    Tao QF; Soszynski PA; Hollenberg NK; Graves SW
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):859-63. PubMed ID: 7564329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Na+,K+-ATPase isoenzymes: sensitivity to prednisolone bisguanylhydrazone.
    Ng YC; Leung WY; Akera T
    Eur J Pharmacol; 1988 Oct; 155(1-2):93-9. PubMed ID: 2854075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of ouabain and human ouabainlike substance to different Na+, K+-ATPase isoforms.
    Butt AN; Tennant BP; Gillingwater SD; Shepherd PS; Swaminathan R
    Hypertens Res; 2000 Sep; 23 Suppl():S45-50. PubMed ID: 11016819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The heterogeneity of the Na+, K(+)-ATPase ouabain sensitivity in microsomal membranes of rat colon smooth muscles].
    Kaplia AA
    Ukr Biokhim Zh (1999); 2011; 83(5):89-93. PubMed ID: 22276432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of the high-affinity binding sites for [3H]ouabain in the rat vas deferens and their immunological identification as the alpha 2 isoform of Na+/K(+)-ATPase.
    Noël F; Quintas LE; Freitas E; Caricati-Neto A; Lafayette SS; Wanderley AG; Jurkiewicz A
    Biochem Pharmacol; 1998 May; 55(9):1531-5. PubMed ID: 10076547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.